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Abstract
Background: Serum creatinine (SCR) is the most important biomarker for a quick and non-invasive assessment of
kidney function in population-based surveys. A substantial proportion of the inter-individual variability in SCR level is
explicable by genetic factors.
Methods: We performed a meta-analysis of genome-wide association studies of SCR undertaken in five population
isolates (’discovery cohorts’), all of which are part of the European Special Population Network (EUROSPAN) project.
Genes showing the strongest evidence for an association with SCR (candidate loci) were replicated in two
additional population-based samples (’replication cohorts’).
Results: After the discovery meta-analysis, 29 loci were selected for replication. Association between SCR level and
polymorphisms in the collagen type XXII alpha 1 (COL22A1) gene, on chromosome 8, and in the synaptotagmin-1
(SYT1) gene, on chromosome 12, were successfully replicated in the replication cohorts (p value = 1.0 × 10
-6 and
1.7 × 10
-4, respectively). Evidence of association was also found for polymorphisms in a locus including the
gamma-aminobutyric acid receptor rho-2 (GABRR2) gene and the ubiquitin-conjugating enzyme E2-J1 (UBE2J1)
gene (replication p value = 3.6 × 10
-3). Previously reported findings, associating glomerular filtration rate with SNPs
in the uromodulin (UMOD) gene and in the schroom family member 3 (SCHROOM3) gene were also replicated.
Conclusions: While confirming earlier results, our study provides new insights in the understanding of the genetic
basis of serum creatinine regulatory processes. In particular, the association with the genes SYT1 and GABRR2
corroborate previous findings that highlighted a possible role of the neurotransmitters GABAA receptors in the
regulation of the glomerular basement membrane and a possible interaction between GABAAreceptors and
synaptotagmin-I at the podocyte level.
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In epidemiological population-based surveys, serum
creatinine (SCR) represents the most important biomar-
ker for a quick and non-invasive assessment of kidney
function, allowing estimation of the glomerular filtration
rate (GFR) [1]. At the same time, an increased SCR level
has also been recognized as a risk factor for adverse out-
comes in patients hospitalized for cardiac surgery or
heart failure [2]. A substantial proportion of the inter-
individual variability in SCR l e v e li se x p l i c a b l eb yg e n e t i c
factors. Twin [3] and pedigree-based studies [4-7]
yielded heritability estimates ranging from 0.19 to 0.53,
with higher values observed in subjects not treated for
hypertension [4]. A large number of genetic loci have
emerged from genome-wide linkage analyses as being
related to variation in SCR level or in SCR-based esti-
mates of both GFR and creatinine clearance [4-15].
Focusing upon quantitative renal phenotypes, a recent
GWA study [16] and a subsequent replication study
[17] identified variants in the 5,10-methenyltetrahydro-
folate synthetase (MTHFS)g e n et ob ea s s o c i a t e dw i t h
chronic kidney disease (CKD; defined as GFR < 60 ml/
min/1.73 m
2). More recently, variants in the uromodulin
(UMOD) gene have been shown to be associated with
GFR and CKD independent of age, sex, hypertension,
and diabetic status [18]. In the same study, SNPs in the
schroom family member 3 (SCHROOM3) gene, the gly-
cine amidinotransferase (GATM)-spermatogenesis asso-
ciated 5-like 1 (SPATA5L1) locus, and in the jagged 1
(JAG1) gene were also found to be associated with GFR
[18].
We have reported linkage between SCR level and a
region at 22q13 containing the myosin heavy chain 9
non-muscle (MYH9) gene [4], a locus that had been
associated with non-diabetic end-stage renal disease
(ESRD) [19,20] and glomerulosclerosis [21] before. This
linkage was detected in families from three isolated Eur-
opean populations participating in the European Special
Population Research Network (EUROSPAN). Here, we
have performed a genome-wide association analysis of
SCR level combining data from all five EUROSPAN
populations, with SCR re-measured using an enzymatic
method in one and the same central laboratory. We
have performed population-specific GWA studies and
subjected the results to an inverse-variance, fixed effects
meta-analysis. Selected candidate regions were then
tested in two additional, population-based samples from
Europe.
Methods
Study samples
For all EUROSPAN and replication studies, written
informed consent was obtained from all participants and
all protocols were approved by the institutional ethical
review committees of the participating centres.
Eurospan
The EUROSPAN project http://homepages.ed.ac.uk/
s0565445/index.html was initiated in 2006 and involves
five population isolates from Italy, Croatia, Scotland,
Sweden, and the Netherlands. The project aims at asses-
sing the genetic structure of European isolates and at
identifying genes underlying common traits, taking
advantage of the genetic and environmental homogene-
ity that usually characterizes population isolates. In the
current context, according to Neel [22], with population
isolates we mean “secondary isolates”,i . e .g r o u p st h a t ,
for some reasons, detached or were detached from lar-
ger populations. In particular, EUROSPAN cohorts were
derived from small population samples which have
grown slowly, with little recruitment from outside the
groups.
The ERF study is a family-based project including over
3000 participants that originated from 22 couples living
in the Rucphen region of the Netherlands in the 19
th
century [23-25]. All descendants of these people were
invited to visit a clinical research center in the region,
where they were examined in person and where blood
was taken after fasting. Height and weight were mea-
sured for each participant. All participants filled out a
questionnaire on risk factors.
The MICROS study is part of the genomic health care
program ‘GenNova’ and was carried out in three villages
of the Val Venosta, South Tyrol (Italy), in 2001-2003. It
comprised members of the populations of Stelvio, Valle-
lunga and Martello. A detailed description of the
MICROS study can be found elsewhere [26]. Briefly,
study participants were volunteers from three isolated
villages located in the Italian Alps, in a German-speak-
ing region bordering upon Austria and Switzerland.
Owing to geographical, historical and political reasons,
the entire region experienced a prolonged period of iso-
lation from surrounding populations. Information on
the participants’ health status was collected through a
standardized questionnaire. Laboratory data were
obtained from standard blood analyses. Genotyping was
performed on >1400 participants, with 1334 of them
suitable for analysis after data cleaning.
The Northern Swedish Population Health Study
(NSPHS) is a family-based study including a comprehen-
sive health assessment and the collection of data on
family structure, lifestyle, diet, medical history and of
samples for laboratory analyses [27,28]. Participants
came from the northern part of the Swedish mountain
region (County of Norrbotten, Parish of Karesuando).
Historic population accounts show that little migration
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the last 200 years.
T h eO r k n e yC o m p l e xD i s e a s eS t u d y( ORCADES)i s
an ongoing, family-based and cross-sectional study in
the isolated Scottish archipelago of Orkney [29].
Genetic diversity in this population is reduced in com-
parison to Mainland Scotland, consistent with high
levels of historical endogamy. Participants were aged
18-100 years and came from a subgroup of ten islands.
Fasting blood samples were collected and over 200
health-related phenotypes and environmental expo-
sures were measured in each individual.
The Vis study includes 986 unselected Croatians, aged
18-93 years, who were recruited during 2003 and 2004
from the villages of Vis and Komiza on the Dalmatian
island of Vis [30,31]. The settlements on Vis island have
a unique history and remainedi s o l a t e df r o mo t h e rv i l -
lages and the outside world for centuries. Participants
were phenotyped for 450 disease-related quantitative
traits. Biochemical and physiological measurements were
performed, detailed genealogies reconstructed, question-
naires on lifestyle and environmental exposures col-
lected, and blood samples and lymphocytes extracted
and stored for further analyses.
All DNA samples were genotyped on Illumina Infi-
nium HumanHap300 v2 SNP bead microarrays accord-
ing to the manufacturer’s instructions, except for
samples from Vis for which version 1 was used (the Vis
samples had 311,398 SNPs genotyped in common with
the other populations).
For all five studies, serum or plasma creatinine was
measured at the Institute for Clinical Chemistry and
Laboratory Medicine, Regensburg University Medical
Center, Germany, using an enzymatic photometric assay
on an ADVIA1650 clinical chemistry analyzer (Siemens
Healthcare Diagnostics GmbH, Eschborn, Germany)
[32]. The number of individuals with available creati-
nine, sex, and age information is reported for each study
in Table 1.
Replication Cohorts
Data on German healthy control individuals were
obtained from the popgen biobank [33]. Genotyping
constituted an essential part of the GWAS initiative of
the German National Genome Research Network
(NGFN) and was performed at an Affymetrix service
facility (South San Francisco, CA, USA) using the Affy-
metrix Genome-Wide Human SNP Array 6.0 (1000 k)
(Santa Clara, CA, USA). Genotype calling was carried
out using Affymetrix’ Birdseed v2 algorithm with default
quality thresholds. Samples with more than 5% missing
genotypes, showing excess genetic dissimilarity to the
remaining subjects, or with evidence for a cryptic relat-
edness to other study participants were removed. These
quality control measures left 1213 control samples for
inclusion in the replication cohort. All sex assignments
could be verified by reference to the proportion
of heterozygous SNPs on the X chromosome. Serum
creatinine was available for 1140 individuals and was
measured at the Institute for Clinical Chemistry in Kiel,
Germany, using an enzymatic in vitro assay (CREAplus,
Cobas®, Roche Diagnostics, Indianapolis, IN).
The Korcula study included 944 unselected 18-98 year
old Croatians, recruited into the study during 2007 from
Table 1 Characteristics of studies and study participants.
EUROSPAN REPLICATION STUDIES
Study name ERF MICROS NSPHS ORCADES VIS popgen Korcula
Nationality The Netherlands Italy Sweden UK Croatia Germany Croatia
Population type isolated isolated isolated isolated isolated general isolated
Genotyping platform Illumina 318 K Illumina 318 K Illumina 318 K Illumina 318 K Illumina 318 K Affymetrix 1000 K Illumina 370 K
Sample size* 775 1086 653 718 774 1140 895
Females: n (%) 472 (61%) 615 (57%) 345 (53%) 385 (54%) 454 (59%) 534 (47%) 572 (64%)
Age: mean (sd) 53 (15) 45 (16) 47 (21) 54 (16) 57 (15) 54 (15) 56 (14)
Diabetes: n (%) 36 (4.9%) 39 (3.6%) 44 (6.7%) 21 (3.0%) 72 (9.4%) 18 (1.6%) 93 (10.3%)
AHT
#: n (%) 190 (24.5%) 85 (7.8%) 124 (19.0%) 152 (21.2%) 192 (25.2%) Not available 197 (22.0%)
SCR mg/dl: mean (sd)
Males 1.01 (0.20) 0.96 (0.14) 0.94 (0.20) 0.97 (0.15) 1.01 (0.31) 0.93 (0.15) 0.92 (0.15)
Females 0.85 (0.21) 0.78 (0.12) 0.75 (0.14) 0.77 (0.19) 0.79 (0.27) 0.74 (0.12) 0.75 (0.12)
eGFR
† ml/min/1.73 m
2
Males 81.1 (19.0) 87.8 (15.1) 92.2 (22.1) 84.3 (16.0) 82.0 (19.4) 88.0 (17.5) 77.1 (14.9)
Females 75.8 (20.5) 83.4 (16.8) 88.7 (19.2) 81.5 (18.5) 81.0 (19.8) 85.5 (17.2) 72.4 (14.1)
* Number of individuals with available creatinine, sex, and age information.
# AHT: Anti-hypertensive treatment
† Estimated using the updated abbreviated MDRD study equation [58]
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included the Eastern region of the island, which has a
unique population history and has maintained a high
level of isolation from other mainland populations and
from the Western part of the island. Participants were
phenotyped for >400 disease-related quantitative traits.
Biochemical and physiological measurements were per-
formed, genealogies reconstructed, questionnaires on
lifestyle and environmental exposures collected, and
blood samples and lymphocytes extracted and stored for
further analyses. DNA was genotyped using the Illumina
Infinium HumanCNV370v1 SNP bead microarrays.
Serum creatinine as measured by the Jaffé rate method
was available for 895 individuals.
Statistical analysis
To ensure normality within centers and comparability of
SCR values across centers, we applied a quantile normali-
zation in all discovery and replication studies, which
involves ranking all SCR values and converting them to
z-scores according to a standard normal distribution.
Discovery stage
To account for inter-individual relatedness within the
five EUROSPAN cohorts, genome-wide association
(GWA) analysis was carried out following a two stage
approach. In the first stage, a sex- and age-adjusted lin-
ear model was fitted to the normalized SCR in order to
estimate the residuals. A polygenic model was then
fitted to estimate the inverse of the variance-covariance
matrix, which accounts for the inter-individual related-
ness and is based upon a genomic kinship matrix as
described in Amin et al. [35]. The association between
SNPs and residuals was assessed by means of an approx-
imate score test statistic [36], assuming an additive
model, as implemented in the GenABEL package [37].
The results from the five EUROSPAN cohorts were
then combined into a fixed-effects meta-analysis with
inverse-variance weighting, using MetABEL http://mga.
bionet.nsc.ru/~yurii/ABEL/. Only SNPs that had a call
rate ≥ 0.95, a Hardy-Weinberg equilibrium (HWE) test
pv a l u e>1 0
-6 and a minor allele frequency (MAF) ≥
0.01 were included in the analyses. In total, 322,498
SNPs were tested for association with SCR.T h et h r e s h -
old for genome-wide statistical significance, according to
Bonferroni adjustment for multiple testing, was set to
1.55 × 10
-7. Between-study heterogeneity was quantified
using the I
2 statistic, i.e. the percentage of total variation
explained by heterogeneity rather than sampling error
[38].
Replication stage
In the absence of clear methodological guidance on
what may be the best strategy for passing SNPs to a
replication stage, we selected SNPs for replication based
on a tradeoff that enabled us to include our best
findings from the discovery analysis, whilst avoiding the
risk of an excessively long list. This was achieved by
including all SNPs with a p value ≤ 10
-5, but also allow-
ing for SNPs with higher p values to get into the repli-
cation list in the presence of additional evidence for
association provided by other SNPs within 100 kb. The
following criteria were applied: (i) at least one p value ≤
10
-5;( i i )a tl e a s to n epv a l u e≤ 10
-4 and at least one
additional SNP with p value ≤ 10
-3 within 100 kb; (iii) at
least three SNPs with p value ≤ 10
-3 within 100 kb. For
each group of candidate SNPs, we selected a candidate
gene (all SNPs included in the gene were considered for
replication) or region (all SNPs included within ± 100
kb of the candidate SNPs were considered for replica-
tion) to test in the independent cohorts of Korcula and
popgen. The complete workflow of the test procedure is
depicted in Figure 1.
In popgen, the association between SCR and each SNP
within a candidate region was assessed by means of a
sex- and age-adjusted linear regression model assuming
additive genetic effects, using PLINK version 1.05 http://
pngu.mgh.harvard.edu/purcell/plink/[39]. For Korcula,
given that it is a family-based study, we used the same
approach as described above for the EUROSPAN
cohorts.
To assess the significance in the replication cohorts of
associations with different SNPs from those genotyped
in the discovery cohorts, we defined region-specific p
values as follows: for a genomic region containing N
SNPs, we counted the number n of SNPs that achieved
p value < 0.05. Assuming that p values are uniformly
distributed between 0 and 1 under the null hypothesis
of no association, the distribution function of n, F(.),i s
that of a binomial with parameters N and 0.05. The
region-specific p value then equals 1-FN,0.05(n-1).G i v e n
that in small genomic regions the assumption of inde-
pendency is rarely met, the estimated p value should be
considered as conservative since the effective number of
independent tests can only be lower than the total num-
ber of SNPs tested. Meta-analysis of region-specific p
values from popgen and Korcula was finally performed
using the Fisher’s combined probability test [40], which
is suitable for combining tests performed in independent
samples. We further evaluated rejection of the null
hypothesis of no association based on a false discovery
rate (FDR) of 0.05 [41], where p values are sorted in
ascending order and the first k tests with p value ≤ i/
m × a are considered significant (in our case, i=1 . . 2 9 ,
m=2 9 , a = 0.05).
Replication of previous findings
We finally assessed whether any of the four loci
reported to be associated with eGFR by Köttgen et al.
[18] showed evidence for an association with SCR in our
discovery meta-analysis. Köttgen et al. reported four
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(SHROOM3), rs2467853 (SPATA5L1-GATM),
rs12917707 (UMOD), and rs6040055 (JAG1). For each
of the four SNPs, we defined LD blocks around them,
following the method by Gabriel et al.[ 4 2 ]a n du s i n g
SNPs with MAF ≥ 1% from the HapMap-CEU database,
Phase III/Release 2. Given that the genes were in four
independent loci, the threshold for claiming significant
replication, according to Bonferroni, was set to 0.05/4 =
0.0125. To compare our results with the commonly
used method of testing replication at the same SNP or
at a proxy SNP, we repeated the test procedure at one
SNP per locus, using the same threshold for statistical
significance.
If not specified otherwise, all data management, data
analysis, programming, and the creation of graphs were
performed using R 2.8.0 [43].
Results
Study-specific characteristics of the participants are
reported in Table 1. A total of 4006 individuals were
included in the meta-analysis whilst the replication
cohorts comprised 2035 individuals. All EUROSPAN
cohorts comprised a higher percentage of females
(between 53% and 61%) than males. The mean age ran-
ged from 45 years in MICROS to 57 years in VIS. The
replication samples had a similar age range, but a smal-
ler percentage of females than males included in
popgen.
The results of the GWA meta-analysis are depicted in
Figure 2. The genomic control factor (l), as assessed by
the quantile-quantile plot included in Figure 2, was
1.004 (SE < 10
-5), indicating that no cryptic relatedness
or gross population structure affected our results [44].
The smallest p value in the meta-analysis was 1.5 ×
10
-6 and was obtained for SNP rs2396463 in the col-
lagen type IV alpha-3 (COL4A3) gene on chromosome
2q. In the absence of hits of genome-wide significance,
we selected a set of promising regions for follow-up in
two independent replication samples, namely Korcula
(an island population from Croatia) and popgen (a ran-
dom population sample from the most northern part of
 
 
 
Figure 2 Manhattan plot of -log10 (p values) from the meta-analysis of five GWA studies. GWA results were combined across all studies
by fixed-effects meta-analysis using inverse variance weighting. Square dots indicate SNPs satisfying criteria for selection of candidate regions.
SNPs within replicated regions are colored in dark red and SNPs within non-replicated regions in pink. The genomic control factor of l = 1.004,
assessed by the quantile-quantile plot in the upper-right panel, indicates that cryptic relatedness and population structure have been modeled
appropriately.
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ered for replication. The full list of regions and the
results of the discovery meta-analysis are provided in
the Additional file 1 - Table S1. Since the SNP panels
genotyped in the replication samples differed from one
another and from that used in the discovery GWA stu-
dies, all markers present in the candidate regions were
included in the replication phase. A total of 2224 SNPs
were analyzed in the popgen samples and 1136 SNPs
were analyzed in the Korcula samples. Results of the
replication analysis are fully reported in the Additional
file 1 - Table S2, with loci sorted by significance.
Two candidate regions from the discovery GWA stu-
dies also showed significant evidence for an association
with SCR level in the popgen and Korcula samples after
Bonferroni correction for multiple testing of the com-
bined p value (significance threshold for 29 independent
tests: a = 0.0017). When controlling for the FDR, i.e. for
the probability of reporting a false positive result, a
third region could be added to the list of replicated find-
ings (Figure 3).
The first replicated region was defined by four SNPs
(rs4075073, rs4588898, rs9324496, and rs2873682) in
the collagen type XXII alpha 1 (COL22A1) gene, all of
which yielded p values ≤ 9.79 × 10
-4 in the meta-analy-
sis of the discovery stage, with homogeneous effects
observed across populations: I
2 =0 %f o ra l lt h ef o u r
SNPs. A forest plot of the marker with the strongest evi-
dence for association, SNP rs4588898, is provided in
Figure 4A. Six other SNPs in the gene (out of 72) had
p values between 3.42 × 10
-3 and 0.0414 (Table 2). As it
c a nb ei n f e r r e df r o mF i g u r e5 ,s o m e1 9o f1 4 0
COL22A1 SNPs genotyped in popgen were found to be
significantly associated with SCR (red squares), as were
1 1o u to f7 1S N P si nK o r c u l a( g r e e ns q u a r e s ) .F i s h e r ’s
combined probability test p value was 1.0 × 10
-6. Never-
theless, the gene regions with the strongest SCR associa-
tion in EUROSPAN and either popgen or Korcula failed
Figure 3 Results of the false discovery rate analysis.- l o g 10 (Fisher p value) of the replication analysis (orange) and -log10 (significance
thresholds) for FDR (black) are plotted for each candidate locus. According to [41], FDR thresholds have been calculated as i/m × a, with a =
0.05, m = no. of test (i.e.: no. of regions, 29), and i ranging between 1 and 29. After sorting the Fisher p values in ascending order, the first k
tests for which the p value is ≤ threshold are significant.
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blocks. Interestingly, however, the smallest p values for
popgen and Korcula fell into the same LD block.
Three closely linked SNPs (rs10506807, rs12300068,
and rs11112829) on chromosome 12q21, yielded
pv a l u e s≤ 7.55 × 10
-5 in the EUROSPAN discovery
meta-analysis. I
2 for heterogeneity was 21.88%, 24.11%,
and 19.94%, respectively, none of which was statistically
significant. A forest plot for SNP rs12300068 is provided
in Figure 4B. Depending upon the annotation of the 5’-
UTR sequence, all SNPs are located either >100 kb
upstream (NCBI) or directly inside (Ensembl and
UCSC) the synaptotagmin-1 (SYT1) gene. In the popgen
sample, nine SNPs located less than 50 kb upstream of
the three discovery SNPs were significantly associated
with SCR, with p values between 2.0 × 10
-5 and 8.5 ×
10
-3 (Table 3). The Fisher’s combined probability test
p value for the whole region was as low as 1.7 × 10
-4.
The third locus was defined by the four SNPs
rs3777514 (p value = 4.5 × 10
-4), rs2064831 (p value =
7.2 × 10
-5), rs1998576 (p value = 8.6 × 10
-5), and
rs7744005 (p value = 3.6 × 10
-4). The effect of the three
SNPs upon SCR level was homogeneous across popula-
tions, with an I
2 of 2.20% (p value = 0.38), 6.73% (p
value = 0.29), 9.70% (p value = 0.38), and 0.00% (p value
= 0.54), respectively. A forest plot of the SNP with the
strongest evidence for association (rs2064831), is
reported in Figure 4C. The SNPs in question are located
in a region on chromosome 6q15 containing the
gamma-aminobutyric acid receptor rho-2 (GABRR2) and
the ubiquitin-conjugating enzyme E2-J1 (UBE2J1)g e n e s
(Figure 6). Five additional SNPs (out of a total of 28
SNPs tested) in this region had p values between 2.2 ×
10
-3 and 0.0280 (Table 4). Of the 37 SNPs genotyped in
the popgen sample, eight were associated with SCR with
apv a l u e≤ 0.05; seven of them overlapped with the
GABRR2 and UBE2J1 genes (see the blue squares
in Figure 6). The most consistent association signals in
EUROSPAN and popgen were found near the GABRR2
gene and its promoter, and the respective SNPs were in
linkage disequilibrium (r
2 > 0.59, Figure 6, middle
panel). SNP rs12195070 was genotyped in both EURO-
SPAN and popgen: effect direction was discordant but
in both cases association was very significant with
p values of 4.5 × 10
-3 in EUROSPAN and p value = 7.2
×1 0
-3 in popgen, respectively. In the Korcula samples,
the smallest p value in the region was 0.0616 so that we
cannot formally claim replication in this population.
However, Fisher’sc o m b i n e dp r o b a b i l i t yt e s tpv a l u e
equaled 3.6 × 10
-3. This value does not meet the Bonfer-
roni threshold for multiple testing, but it does meet the
FDR threshold of 0.0052, which controls the probability
of reporting false positives at a 0.05 level (see Additional
file 1 - Table S2 and Figure 3). Detailed results for this
locus are reported in Table 4.
Although consistently observed in all EUROSPAN
populations (Figure 4D), the association noted between
SCR and the COL4A3 gene could not be verified in the
Figure 4 Forest plots of betas and standard errors, with 95% confidence intervals, for the most significant SNPs in the three
replicated loci (A, B, and C) and for the most significant SNP of the discovery meta-analysis (D). The pooled estimate was obtained with
a fixed-effect meta-analysis using the metafor package in R http://www.wvbauer.com/index.htm.
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p value = 0.216).
Unfortunately, the number of people with diabetes
included in the EUROSPAN populations was too small
to allow any meaningful subgroup analysis, adjusting for
disease state. However, when we repeated our GWA
meta-analysis in non-diabetic subjects only, the p values
for the three replicated gene regions changed so little
that any strong interaction of the respective loci with
diabetes status appears rather unlikely.
Results of the replication analysis at the four loci
reported to be associated with eGFR by Köttgen et al.
[18] are reported in the Additional file 1 - Table S3. We
identified three SNPs in the UMOD gene locus:
Table 2 SNPs showing the highest evidence of association in the COL22A1 gene (chromosome 8).
#
study name position Genotype (Ref. All.) Ref. All. Freq. n Beta* SE p value**
EUROSPAN rs4075073 139808143 A/C (A) 0.37 3996 0.0671 0.0203 9.8 × 10
-4
EUROSPAN rs4588898 139815390 A/G (A) 0.30 3999 0.0786 0.0212 2.1 × 10
-4
EUROSPAN rs13255079 139828786 C/T (T) 0.16 4001 0.0769 0.0263 3.4 × 10
-3
EUROSPAN rs9324496 139833578 C/T (T) 0.34 3995 0.0716 0.0205 4.6 × 10
-4
EUROSPAN rs7824025 139839898 A/C (A) 0.07 3998 0.0762 0.0374 0.0414
EUROSPAN rs2873682 139840693 A/G (A) 0.30 2610 0.0915 0.0264 5.2 × 10
-4
EUROSPAN rs11166844 139848062 C/T (C) 0.39 3993 0.0485 0.0202 0.0166
EUROSPAN rs1574172 139941802 A/G (A) 0.14 3998 -0.0713 0.0284 0.0122
EUROSPAN rs4736078 139944298 C/T (C) 0.22 3996 -0.0503 0.0242 0.0373
EUROSPAN rs6986041 139988449 C/T (C) 0.35 3936 -0.0583 0.0207 4.8 × 10
-3
POPGEN rs4282617 139795530 C/G (C) 0.25 1139 -0.0822 0.0398 0.0391
POPGEN rs10092896 139856976 C/T (C) 0.27 1139 -0.1123 0.0380 3.1 × 10
-3
POPGEN rs2318334 139859320 C/T (C) 0.25 1140 -0.1115 0.0390 4.2 × 10
-3
POPGEN rs1574370 139866164 A/G (A) 0.24 1126 -0.0992 0.0402 0.0137
POPGEN rs6991720 139871695 C/G (G) 0.25 1139 -0.1074 0.0391 6.1 × 10
-3
POPGEN rs7837787 139875897 A/G (G) 0.25 1140 -0.1106 0.0391 4.7 × 10
-3
POPGEN rs12155960 139886087 A/G (G) 0.26 1134 -0.1152 0.0388 3.0 × 10
-3
POPGEN rs11779129 139888085 A/C (A) 0.25 1140 -0.0992 0.0388 0.0105
POPGEN rs16893541 139890024 C/G (C) 0.27 1124 -0.1089 0.0390 5.2 × 10
-3
POPGEN rs12549194 139896019 A/C (C) 0.26 1137 -0.0830 0.0388 0.0327
POPGEN rs10093925 139904787 C/T (T) 0.36 1124 -0.0687 0.0347 0.0478
POPGEN rs6577953 139914021 C/G (C) 0.40 1139 -0.1032 0.0336 2.1 × 10
-3
POPGEN rs6993839 139914702 A/G (G) 0.39 1131 -0.1029 0.0342 2.6 × 10
-3
POPGEN rs9650564 139918011 C/T (C) 0.41 1139 -0.1017 0.0338 2.6 × 10
-3
POPGEN rs9650565 139918089 C/T (C) 0.41 1133 -0.0944 0.0339 5.3 × 10
-3
POPGEN rs7014497 139923457 C/T (C) 0.39 1133 -0.0892 0.0341 8.9 × 10
-3
POPGEN rs9650566 139923872 A/G (G) 0.46 1139 -0.1054 0.0332 1.5 × 10
-3
POPGEN rs17740495 139941879 C/T (C) 0.08 1136 0.1393 0.0603 0.0209
POPGEN rs16893545 139948143 A/C (C) 0.18 1140 0.0953 0.0440 0.0304
KORCULA rs4076439 139690550 A/G (G) 0.25 895 0.0907 0.0393 0.0209
KORCULA rs4341165 139692067 C/T (C) 0.25 895 0.0907 0.0393 0.0209
KORCULA rs4909439 139727929 C/T (C) 0.17 895 0.1080 0.0518 0.0371
KORCULA rs3923549 139732799 C/T (T) 0.10 895 0.1513 0.0704 0.0316
KORCULA rs4073446 139735056 C/T (T) 0.11 895 0.1555 0.0658 0.0182
KORCULA rs7839680 139762863 A/G (A) 0.18 895 0.0950 0.0472 0.0440
KORCULA rs4909444 139770391 G/T (T) 0.38 895 0.0623 0.0289 0.0309
KORCULA rs4074052 139785008 C/T (T) 0.46 894 -0.0504 0.0248 0.0419
KORCULA rs10112806 139806115 A/C (C) 0.41 895 -0.0589 0.0280 0.0357
KORCULA rs1320279 139899978 C/T (C) 0.11 895 -0.1823 0.0662 5.9 × 10
-3
KORCULA rs2318345 139970360 C/T (C) 0.09 894 0.1755 0.0720 0.0147
# association models were adjusted for age and sex; *in standard deviations; **p value: for EUROSPAN, the p value refers to the meta-analysis of the five
individual GWA studies, for popgen and Korcula, the p value is from the linear regression analysis (for details, see Methods).
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Page 9 of 17rs4293393 was significantly associated with SCR level (p
value = 3.9 × 10
-4) and weaker signals were observed for
rs11647727 (p value = 0.011) and rs4506906 (p value =
0.028). The region-specific p value for this locus was
1.3 × 10
-4. Of the five SNPs identified in the SPA-
TA5L1-GATM locus, rs1153860, rs1346268, and
rs1719247 were associated with SCR at p values of 5.0 ×
10
-4,1 . 9×1 0
-3, and 4.6 × 10
-3, respectively (region-spe-
cific p value = 1.2 × 10
-3). At the SCHROOM3 gene
locus, 53 SNPs were tested: three of them resulted in a
pv a l u e≤ 0.05 (region-specific p value = 0.50). The
smallest p value of 1.7 × 10
-3 was observed for SNP
Figure 5 Genomic structure and association results at the COL22A1 locus. Upper panel:- l o g 10(p values) are plotted by physical position
for the EUROSPAN discovery meta-analysis (red squares), the popgen (blue squares) and the Korcula (green squares) replication cohorts. Middle
panel: linkage disequilibrium (LD) as quantified by r
2 (the higher the LD, the darker the color, with black indicating perfect LD), based upon the
HapMap-CEU database, Phase III/Release 2, (NCBI build 36). Lower panel: genes located in the plotted region, with coding exons indicated by
black rectangles and orientation.
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Page 10 of 17rs4859682 (this SNP was in strong LD with the
rs17319721 reported in the paper, r
2 =0 . 9 4 ) .N o n eo f
the 8 polymorphisms tested in the JAG1 gene was sig-
nificantly associated with SCR level, including the
rs6040055 which was included in our database as well.
Our conclusions would have been slightly different had
we attempted replication at the level of the individual
variants rather than at the locus level. In this case, also
the SCHROOM3 locus would have been replicated.
Discussion
The main result of our study was the identification of
three novel genetic associations with SCR level. These
were detected in a meta-analysis of five European iso-
lated population samples and replicated in two indepen-
dent population samples, one from the general Central-
European population (popgen), and one from another
isolate (Korcula). The replicated loci included the
COL22A1 gene on chromosome 8 and the SYT1 gene
on chromosome 12. The third locus, including the
GABRR2 and UBE2J1 genes on chromosome 6, showed
substantial evidence of association as well. In addition,
the association of two loci (UMOD and SPATA5L1-
GATM)a n do n eS N Pi nt h eSCHROOM3 locus, pre-
viously reported with GFR, was also found to apply to
SCR. This confirmation also supports our choice of using
SCR adjusted by age and sex which is equivalent to study
GFR calculated from SCR weighted by age and sex [1]
(black or white ethnicity, which should also be
accounted for, was not relevant in our study involving
individuals of European origin).
The two SNPs with the strongest evidence for associa-
tion in the discovery stage of our study were located in
the promoter region of the COL4A3 gene, which is
expressed in the glomerular basement membrane
(GBM) of the kidney, and which has been associated
with Alport syndrome, Goodpasture syndrome [45] and
benign hematuria [46]. Despite making biological sense,
however, the association between COL4A3 and SCR as
observed in our meta-analysis could not be verified in
the replication stage. On the one hand, this could be
interpreted to indicate that no common variants of that
gene are involved in the regulation of kidney function.
On the other hand, the lack of replication could be due
either to the involvement of the gene in regulatory path-
ways, implying a strong interaction with other genes, or
to a particularly prominent interaction with population-
specific environmental conditions [47].
In any case, a slightly less significant association
between three other genes and SCR from the discovery
meta-analysis could be replicated in either the popgen
or the Korcula data. Different SNPs in the COL22A1
gene were found to be associated with SCR in all discov-
ery and replication cohorts. This association may reflect
the biological relationship between muscle mass forma-
tion and creatinine levels. In fact, in situ hybridization
of myotendinous junctions has revealed that muscle
cells produce collagen XXII, and functional tests have
shown that collagen XXII acts as a cell adhesion ligand
for skin epithelial cells and fibroblasts [48].
The discovery stage association of SCR with the SYT1
gene was well replicated in the popgen sample. Even
though the annotation of gene reference sequences is
not uniform across different databases (NCBI, UCSC,
Ensembl), the associated SNPs are located in the fourth
a n dl a s ti n t r o no ft h e5 ’ SYT1 un-translated region
Table 3 SNPs with the highest evidence of association in the region upstream the SYT1 gene.
#
Study name position Genotype (Ref. All.) Ref. All. Freq. n Beta* SE p value**
EUROSPAN rs11838060 77997790 G/T (T) 0.14 3163 -0.0696 0.0312 0.0258
EUROSPAN rs10506807 78005428 C/T (C) 0.13 4000 -0.1141 0.0287 7.0 × 10
-5
EUROSPAN rs12300068 78005502 A/G (A) 0.13 3997 -0.1158 0.0288 5.7 × 10
-5
EUROSPAN rs7972593 78013149 C/T (T) 0.12 3989 -0.0978 0.0300 1.1 × 10
-3
EUROSPAN rs11112829 78029267 C/T (C) 0.13 4000 -0.1135 0.0287 7.5 × 10
-5
POPGEN rs12312807 77957336 A/G (A) 0.11 1139 0.1480 0.0539 6.1 × 10
-3
POPGEN rs1527119 77964145 G/T (G) 0.11 1139 0.1471 0.0539 6.4 × 10
-3
POPGEN rs1033196 77966968 C/T (T) 0.14 1128 0.1320 0.0479 5.8 × 10
-3
POPGEN rs2950383 77973538 A/G (A) 0.37 1103 -0.1553 0.0359 2.0 × 10
-5
POPGEN rs1356022 77974533 C/T (C) 0.14 1140 0.1300 0.0475 6.2 × 10
-3
POPGEN rs12317960 77977824 C/T (T) 0.14 1140 0.1249 0.0474 8.5 × 10
-3
POPGEN rs10506806 77979113 C/T (T) 0.31 1120 0.1012 0.0362 5.1 × 10
-3
POPGEN rs11610381 77979918 C/T (C) 0.14 1134 0.1321 0.0476 5.5 × 10
-3
POPGEN rs7971081 77980051 C/T (C) 0.14 1140 0.1296 0.0474 6.3 × 10
-3
# association models were adjusted for age and sex; *in standard deviations; **p value: for EUROSPAN, the p value refers to the meta-analysis of the five
individual GWA studies, for popgen, the p value is from the linear regression analysis (for details, see Methods).
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Page 11 of 17Figure 6 Genomic structure and association results at the GABRR2-UBE2J1 locus. Upper panel:- l o g 10(p values) are plotted by physical
position for the EUROSPAN discovery meta-analysis (red squares), the popgen (blue squares) and the Korcula (green squares) replication cohorts.
Middle panel: linkage disequilibrium (LD) as quantified by r
2 (the higher the LD, the darker the color, with black indicating perfect LD), based
upon the HapMap-CEU database, Phase III/Release 2, (NCBI build 36). Lower panel: genes located in the plotted region, with coding exons
indicated by black rectangles and orientation.
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Page 12 of 17(UTR), suggesting a regulatory role for this locus. Data
on the clones available from public databases clearly
show that SYT1 transcription starts around 77,782 kb
and 77,963 kb on chromosome 12 and that the tran-
scripts are spliced in the 5’UTR region (see, among
others, the mRNA clones with GI numbers 37589129,
21753708, 34533586, 34366268, 37589129, 164696663).
The synaptotagmins are integral membrane proteins of
synaptic vesicles thought to serve as Ca(2+) sensors in
the process of vesicular trafficking and exocytosis [49].
Of particular interest in the present context is expres-
sion of the SYT1 gene product, synaptotagmin-I, in
renal podocytes. Glomerular podocytes possess struc-
tures resembling synaptic vesicles and contain gluta-
mate, they co-express Rab3A (a GTPase restricted to
cell types that regulate exocytosis), synapsin, synapto-
physin, and synaptotagmin-I, and undergo spontaneous
and stimulated exocytosis and recycling, with glutamate
release [50]. Synaptotagmin-I plays a role in neurotrans-
mitter release and neurite outgrowth [51] and is thought
to interact with neurotransmitters such as the GABA
receptors, expressed in the GBM. It also appears to par-
ticipate in the regulation of podocyte homeostasis [50].
In light of the findings on the SYT1 gene, the associa-
tion with the UBE2J1 and GABRR2 locus becomes of
high interest. The association detected in the EURO-
SPAN data was corroborated by the popgen data. More-
over, SNPs associated with SCR in popgen enabled us to
narrow down the associated region to the GABRR2 pro-
moter. The same locus was not replicated in Korcula
data. However, while the popgen genotype distribution
of the SNPs in question was found to resemble that of
the HapMap-CEU samples [52], indicating that popgen
can be considered representative of the general Central
to Northern European populations, this may not be true
for the Korcula sample. In fact, Korcula is a small popu-
lation located in the Croatian islands, where pronounced
genetic isolation is known to have persisted until
recently [53]. This could be the reason of the missed
replication. The GABRR2 gene product is a member of
the rho subunit family of the transmembrane receptors
for gamma-aminobutyric acid (GABAA), which are
linked to potassium channels via G-proteins. GABAA
receptors have been shown to be expressed in the kid-
ney of multiple species, with subunits b1 and b2 loca-
lized in the proximal tubules [54]. More recently, several
subtypes of GABA receptors, including the GABRR2,
have been shown to be transcribed in normal human
glomeruli [50] and it plays a role in retinal neurotrans-
mission [55]. The gene is located close to the GABRR1
gene in the same transcriptional orientation, suggesting
a similar expression and regulatory pattern. Interest-
ingly, the locus falls into the supporting interval for
linkage to SCR reported in Mexican Americans [7], and
to creatinine clearance as reported in Caucasians [9].
Our discovery analysis was performed in five isolated
communities from Southern, Central, and Northern
Europe. As has been demonstrated empirically for South
Tyrolean villages [56], population isolates provide a
reduced within-study heterogeneity of environmental
Table 4 SNPs with the highest evidence of association in the region including the GABRR2 and the UBE2J1 genes
(chromosome 6)
#.
Study GENE name Position Genotype (Ref. All.) Ref. All. Freq. N Beta* SE p value**
EUROSPAN GABRR2 rs6942204 90072687 C/T (C) 0.34 4001 0.0497 0.0213 0.0196
EUROSPAN GABRR2 rs3777514 90077300 A/C (A) 0.20 3998 0.0855 0.0244 4.5 × 10
-4
EUROSPAN Intergenic rs2064831 90089661 C/T (C) 0.18 3995 0.1018 0.0257 7.2 × 10
-5
EUROSPAN Intergenic rs12195070 90090455 C/T (T) 0.19 3998 0.0722 0.0254 4.5 × 10
-3
EUROSPAN UBE2J1 rs1998576 90099856 A/G (A) 0.18 3997 0.0993 0.0253 8.6 × 10
-5
EUROSPAN UBE2J1 rs12189673 90103123 C/T (C) 0.30 3980 -0.0653 0.0213 2.2 × 10
-3
EUROSPAN UBE2J1 rs1065657 90103732 C/T (T) 0.45 3999 0.0499 0.0197 0.0115
EUROSPAN UBE2J1 rs7760851 90109323 A/G (G) 0.49 3980 -0.0505 0.0196 0.0100
EUROSPAN UBE2J1 rs1062108 90132078 C/T (T) 0.42 3996 -0.0435 0.0198 0.0280
POPGEN GABRR2 rs9362633 90058261 A/G (G) 0.05 1136 -0.2430 0.0795 2.2 × 10
-3
POPGEN GABRR2 rs7764923 90079640 C/T (T) 0.23 1140 -0.1144 0.0387 3.1 × 10
-3
POPGEN GABRR2 rs2236204 90081831 G/T (T) 0.17 1121 -0.1190 0.0436 6.4 × 10
-3
POPGEN Intergenic rs10944443 90087709 C/G (C) 0.15 1113 -0.1203 0.0469 0.0103
POPGEN Intergenic rs12195070 90090455 C/T (T) 0.18 1140 -0.1155 0.0430 7.2 × 10
-3
POPGEN Intergenic rs12195078 90090511 C/T (T) 0.15 1128 -0.1261 0.0460 6.1 × 10
-3
POPGEN UBE2J1 rs9048 90094300 C/T (T) 0.18 1139 -0.1230 0.0417 3.1 × 10
-3
POPGEN UBE2J1 rs9351207 90115388 C/T (T) 0.24 1131 -0.0791 0.0387 0.0412
# association models were adjusted for age and sex; *in standard deviations; **p value: for EUROSPAN, the p value refers to the meta-analysis of the five
individual GWA studies, for popgen, the p value is from the linear regression analysis (for details, see Methods).
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Page 13 of 17factors, thereby facilitating the genetic dissection of
complex traits. This internal homogeneity of environ-
mental and life style factors could be counterbalanced
by enhanced between-study heterogeneity. However, this
appears not to have been the case in our study. For
SNPs in 27 of the 29 regions selected for replication, the
hypothesis of homogeneity of effects’ sizes was not
rejected, even at a very stringent significance threshold
(given the small number of studies involved in the
meta-analysis, a was set to 0.10). In particular, homoge-
neity of association signals was verified for all replicated
loci and for the COL4A3 gene locus. This finding
strengthens our results in the sense that, despite the
expected between-population heterogeneity, the results
of the association analyses were found to be very consis-
tent across studies.
Another advantage of our study has been that SCR
values of all EUROSPAN participants were measured in
one and the same centralized laboratory using the enzy-
matic method. In this way, calibration difference could
be excluded as a confounder of our genetic association
analyses. While the enzymatic method was used to mea-
sure SCR in EUROSPAN and popgen participants, the
Jaffé rate method was used in the Korcula study. This
method is known to be less precise than the enzymatic
one. Additional noise introduced by increased measure-
ment error would best explain the reduced evidence for
association replication in the Korcula study. However,
SCR was standardized in all discovery and replication
samples using a transformation based upon the ranks of
a standard normal distribution. The standardization of
the phenotype measures allowed us to combine data
across studies avoiding bias due to technical inter-
laboratory differences.
The validity of our analysis was also evidenced by the
replication of earlier association findings [18]. Associa-
tion of SCR with UMOD and SPATA5L1-GATM was
confirmed using the same replication approach used in
our own analysis. With our method, however, we could
not replicate the association over the SCHROOM3 locus
(the locus would be confirmed if using a classic replica-
tion based on the specific SNP or a proxy SNP). This
finding could be an indication that our method of repli-
c a t i o ni sm o r el i k e l yt ob ec o n s e r v a t i v ea n d ,s o ,l e s s
prone to false positive results. In the COL22A1 and the
SYT1 genes the replicated signals were located in differ-
ent LD blocks, highlighting the possibility that different
polymorphisms at the same locus may be associated
with the same phenotype in different populations. In the
GABRR2 - UBE2J1 gene locus, association signals
between discovery and replication studies were discor-
dant but clearly overlapping. Whether the discordance
of the effect alleles is an indication of a false positive
result is very unlikely, given the size of the effects in
EUROSPAN and in popgen. The presence of a flip-flop
phenomenon [57] could be hypothesized and should be
investigated further.
Conclusions
In conclusion, in addition to confirming earlier findings,
our search for genes associated with SCR variation led to
the discovery of three novel genes that represent sensi-
ble candidates for further functional analysis. The recent
hypothesis of an important role of neurotransmitters in
the regulation of the GBM at the podocyte level [50]
renders our findings particularly relevant for under-
standing the regulation of renal function, suggesting
that the possible interaction between SYT1 and
GABRR2 warrants further investigation.
Additional file 1: Supplementary materials. The file contains
supplementary tables to support the discovery analysis (Table S1), the
replication analysis (Table S2) and the confirmation of previous findings
(Table S3).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2350-11-
41-S1.DOC]
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